Gels (May 2023)

Optimizing Delivery of Therapeutic Growth Factors for Bone and Cartilage Regeneration

  • Eri Takematsu,
  • Matthew Murphy,
  • Sophia Hou,
  • Holly Steininger,
  • Alina Alam,
  • Thomas H. Ambrosi,
  • Charles K. F. Chan

DOI
https://doi.org/10.3390/gels9050377
Journal volume & issue
Vol. 9, no. 5
p. 377

Abstract

Read online

Bone- and cartilage-related diseases, such as osteoporosis and osteoarthritis, affect millions of people worldwide, impairing their quality of life and increasing mortality. Osteoporosis significantly increases the bone fracture risk of the spine, hip, and wrist. For successful fracture treatment and to facilitate proper healing in the most complicated cases, one of the most promising methods is to deliver a therapeutic protein to accelerate bone regeneration. Similarly, in the setting of osteoarthritis, where degraded cartilage does not regenerate, therapeutic proteins hold great promise to promote new cartilage formation. For both osteoporosis and osteoarthritis treatments, targeted delivery of therapeutic growth factors, with the aid of hydrogels, to bone and cartilage is a key to advance the field of regenerative medicine. In this review article, we propose five important aspects of therapeutic growth factor delivery for bone and cartilage regeneration: (1) protection of protein growth factors from physical and enzymatic degradation, (2) targeted growth factor delivery, (3) controlling GF release kinetics, (4) long-term stability of regenerated tissues, and (5) osteoimmunomodulatory effects of therapeutic growth factors and carriers/scaffolds.

Keywords